TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $19,754 | +5.6% | 1,199 | 0.0% | 0.01% | -11.1% |
Q4 2022 | $18,699 | +16.9% | 1,199 | +0.3% | 0.01% | 0.0% |
Q3 2022 | $16,000 | -5.9% | 1,196 | 0.0% | 0.01% | -10.0% |
Q2 2022 | $17,000 | +13.3% | 1,196 | +12.1% | 0.01% | +25.0% |
Q1 2022 | $15,000 | 0.0% | 1,067 | 0.0% | 0.01% | +14.3% |
Q4 2021 | $15,000 | -11.8% | 1,067 | 0.0% | 0.01% | -36.4% |
Q3 2021 | $17,000 | -5.6% | 1,067 | 0.0% | 0.01% | -8.3% |
Q2 2021 | $18,000 | -5.3% | 1,067 | 0.0% | 0.01% | -20.0% |
Q1 2021 | $19,000 | 0.0% | 1,067 | 0.0% | 0.02% | -16.7% |
Q4 2020 | $19,000 | – | 1,067 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |